Literature DB >> 33580568

Health-related quality of life in adults with osteogenesis imperfecta.

Chaya N Murali1,2, Brady Slater1, Salma Musaad3,4, David Cuthbertson5, Dianne Nguyen1, Alicia Turner1, Mahshid Azamian1, Laura Tosi6, Frank Rauch7, V Reid Sutton1,2, Brendan Lee1,2, Sandesh C S Nagamani1,2.   

Abstract

Patient-reported outcome measures (PROMs) are increasingly utilized as endpoints in clinical trials. The Short Form Health Survey-12 (SF-12v2) is a generic PROM for adults. We sought to evaluate the validity of SF-12v2 in adults with osteogenesis imperfecta (OI). Physical and mental health-related quality of life (HRQoL) were assessed in a large cohort of adults in a multicenter, observational, natural history study. Physical HRQoL scores were correlated with the Gillette Functional Assessment Questionnaire (GFAQ). We calculated sample sizes required in clinical trials with crossover and parallel-group designs to detect clinically meaningful changes in physical HRQoL. Three hundred and two adults with OI types I, III, and IV were enrolled. Physical HRQoL scores in the study population were lower than population norms. Physical HRQoL scores moderately correlated with GFAQ for OI types I and IV. We found no correlations between mental and physical HRQoL. From a clinical trial readiness perspective, we show that SF-12v2 reliably measures physical function in adults with OI and can be utilized in crossover trials to detect meaningful physical HRQoL changes with small sample sizes. This study shows that SF-12v2 can be used to measure changes in physical HRQoL in response to interventions in OI.
© 2021 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  natural history; osteogenesis imperfecta; quality of life; sample size

Mesh:

Year:  2021        PMID: 33580568      PMCID: PMC8096695          DOI: 10.1111/cge.13939

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  34 in total

1.  Brief assessment of motor function: reliability and concurrent validity of the Gross Motor Scale.

Authors:  Holly L Cintas; Karen Lohmann Siegel; Gloria P Furst; Lynn H Gerber
Journal:  Am J Phys Med Rehabil       Date:  2003-01       Impact factor: 2.159

2.  Cross-validation of item selection and scoring for the SF-12 Health Survey in nine countries: results from the IQOLA Project. International Quality of Life Assessment.

Authors:  B Gandek; J E Ware; N K Aaronson; G Apolone; J B Bjorner; J E Brazier; M Bullinger; S Kaasa; A Leplege; L Prieto; M Sullivan
Journal:  J Clin Epidemiol       Date:  1998-11       Impact factor: 6.437

3.  A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity.

Authors:  J Ware; M Kosinski; S D Keller
Journal:  Med Care       Date:  1996-03       Impact factor: 2.983

4.  Reliability and validity of the Gillette Functional Assessment Questionnaire as an outcome measure in children with walking disabilities.

Authors:  T F Novacheck; J L Stout; R Tervo
Journal:  J Pediatr Orthop       Date:  2000 Jan-Feb       Impact factor: 2.324

5.  Meaningful changes in the Short Form 12 physical and mental summary scores after total knee arthroplasty.

Authors:  N D Clement; D Weir; J Holland; C Gerrand; D J Deehan
Journal:  Knee       Date:  2019-05-17       Impact factor: 2.199

Review 6.  Minimal important difference to infer changes in health-related quality of life-a systematic review.

Authors:  Ravishankar Jayadevappa; Ratna Cook; Sumedha Chhatre
Journal:  J Clin Epidemiol       Date:  2017-07-01       Impact factor: 6.437

7.  Personality and stereotype in osteogenesis imperfecta: behavioral phenotype or response to life's hard challenges?

Authors:  Joan Ablon
Journal:  Am J Med Genet A       Date:  2003-10-15       Impact factor: 2.802

Review 8.  Patient reported outcome measures in rare diseases: a narrative review.

Authors:  Anita Slade; Fatima Isa; Derek Kyte; Tanya Pankhurst; Larissa Kerecuk; James Ferguson; Graham Lipkin; Melanie Calvert
Journal:  Orphanet J Rare Dis       Date:  2018-04-23       Impact factor: 4.123

Review 9.  To what degree are orphan drugs patient-centered? A review of the current state of clinical research in rare diseases.

Authors:  Sally Lanar; Catherine Acquadro; James Seaton; Isabelle Savre; Benoit Arnould
Journal:  Orphanet J Rare Dis       Date:  2020-06-03       Impact factor: 4.123

10.  Pediatric Outcomes Data Collection Instrument is a Useful Patient-Reported Outcome Measure for Physical Function in Children with Osteogenesis Imperfecta.

Authors:  Chaya N Murali; David Cuthbertson; Brady Slater; Dianne Nguyen; Alicia Turner; Gerald Harris; V Reid Sutton; Brendan Lee; Sandesh C S Nagamani
Journal:  Genet Med       Date:  2019-11-27       Impact factor: 8.822

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.